SharonJShaMDMS(She/Her)

Neurology • Stanford, CA

Movement Disorder, Dementia & Geriatrics

Clinical Professor, Neurology & Neurological Sciences, Stanford University

Join to view full profile

Dr. Sha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sha's full profile

Already have an account?

Office
300 Pasteur Dr RM A343
Stanford, CA 94305
Phone+1 650-723-6469

Summary

Dr. Sharon Sha is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. She received her medical degree from Georgetown University School of Medicine and has been in practice 11 years. She specializes in movement disorder and dementia & geriatrics and is experienced in alzheimer's disease, lewy body dementia, ataxia, huntington disease, and geriatrics / dementia.

Education & Training

University of California (San Francisco)Fellowship, Behavioral Neurology, 2010 - 2013
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2008 - 2010
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2007 - 2008
California Pacific Medical CenterInternship, Internal Medicine, 2006 - 2007
Georgetown University School of MedicineClass of 2006

Certifications & Licensure

CA State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology
United council of neurological sub specialtiesbehavioral neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02) Start of enrollment: 2012 Jul 01
Completed
Phase 1
Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Start of enrollment: 2013 Nov 05
Terminated
Phase 3
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study Start of enrollment: 2014 Sep 01
Completed
Not Applicable
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Start of enrollment: 2015 Sep 15
Terminated
Phase 3
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2015 Nov 30
Terminated
Phase 2, Phase 3
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Start of enrollment: 2016 Mar 22
Terminated
Phase 3
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Start of enrollment: 2017 Aug 03
Terminated
Phase 2, Phase 3
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease Start of enrollment: 2017 Oct 04
Terminated
Phase 2
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease Start of enrollment: 2018 May 03
Terminated
Phase 2
Clinical Trial Readiness for SCA1 and SCA3 Start of enrollment: 2018 Aug 16
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

1 citations
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias.
Louisa P Selvadurai, Susan L Perlman, Tetsuo Ashizawa, George R Wilmot, Chiadi U Onyike
Cerebellum. 2024-08-01
Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation.
Emily Johns, Hillary A Vossler, Christina B Young, Mackenzie L Carlson, Joseph R Winer
Alzheimer's & Dementia. 2024-08-01
2 citations
Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes.
Olamide Abiose, Jarod Rutledge, Patricia Moran-Losada, Michael E Belloy, Edward N Wilson
Alzheimer's & Dementia. 2024-03-01

Journal Articles

Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study
Lu Tian, Gayle K Deutsch, Geoffrey A Kerchner, Sharon J Sha, JAMA